Heart Disease News and Research

Latest Heart Disease News and Research

New guidelines for childhood asthma recommend inhaled corticosteroids

New guidelines aimed at dealing with asthma have been released by government health experts in the United States.

30 Aug 2007

Early surgical removal of the ovaries increases a woman's risk of neurological disorders

New research suggests that premenopausal women who have their ovaries removed have an increased risk of developing neurological disorders such as dementia and Parkinsonism.

30 Aug 2007

Big leap in genomic screening of blood vessels from patient tissue

Scientists have developed a new method of capturing a complete genome-wide screening of blood vessel cells in their actual disease state, advancing the potential for genetic research on the tissue responsible for delivering nourishment that can accelerate the growth of both a cancer tumor or wound healing.

30 Aug 2007

Estrogen protects women's brains prior to menopause

In the largest study of its kind, Mayo Clinic researchers have shown that women who had one or both ovaries removed before menopause faced an increased long-term risk of cognitive impairment or dementia, compared to women who retained their ovaries.

30 Aug 2007

New generation of implanted heart-assisting pumps help patients survive, regain function til transplant

A new generation of implanted heart-assisting pump does very well at helping severely ill heart-failure patients survive, and thrive, until they receive a heart transplant, a new study shows.

30 Aug 2007

Lipid offers new ways of treating inflammatory kidney diseases

Scientists report in the September 2007 issue of the Journal of Lipid Research that a lipid known to protect the heart from inflammation and to cause skin allergic reactions also reduces inflammation of the kidneys.

29 Aug 2007

Genial bone advancement trephine effective treatiment for sleep apnea

Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure to treat obstructive sleep apnea syndrome.

29 Aug 2007

Are all heart palpitations dangerous?

Palpitations - the sensation that the heart has started to race or pound, or feels like it has skipped a beat - are usually caused by a harmless hiccup in the heart's rhythm.

29 Aug 2007

FDA approves cobas TaqScreen WNV test for West Nile virus

The U.S. Food and Drug Administration has announced approval of a second test for the detection of West Nile virus (WNV) in blood and organs.

29 Aug 2007

Do schools need emergency response equipment to deal with heart attacks?

A study by researchers in the U.S. has found that the incidence of heart attacks on school property is rare, and when it does occur most of the victims are adults.

29 Aug 2007

New ESC guidelines on cardiac pacing and cardiac resynchronization therapy

The European Society of Cardiology has released new guidelines for Cardiac Pacing and Cardiac Resynchronization Therapy. These new guidelines cover two main areas: The permanent pacing in bradyarrhythmias, syncope and other specific conditions like hypertrophic obstructive cardiomyopathy and ventricular resynchronization as an adjunct therapy in patients with heart failure.

28 Aug 2007

Early heart treatment can reverse damage

University of Minnesota researchers have discovered that treating people who have early cardiovascular abnormalities, but show no symptoms of cardiovascular disease, can slow progression and even reverse damage to the heart and blood vessels.

28 Aug 2007

Vioxx side-effects explained

Vioxx and related pain medications were taken off the market in 2004 because they caused dangerous heart problems in some people.

28 Aug 2007

Is it safe to use Lybrel to eliminate periods?

The new birth control pill Lybrel is the first oral contraceptive designed to be taken 365 days a year with no pill-free intervals.

28 Aug 2007

IDM Pharma receives not approvable letter for Mifamurtide for treatment of osteosarcoma

IDM Pharma, Inc. ( NASDAQ:IDMI ) announced today that it received a not approvable letter from the U.S. Food and Drug Administration (FDA) after completing the review of the new drug application (NDA) for the investigational drug mifamurtide (L-MTP-PE), formerly known as Junovan, for the treatment of non-metastatic osteosarcoma, a rare and often fatal bone tumor that typically affects children and young adults.

28 Aug 2007